SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001399529-20-000041
Filing Date
2020-05-07
Accepted
2020-05-07 16:31:08
Documents
59
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q drna-20200331.htm   iXBRL 10-Q 1515075
2 EX-10.1 rosskampralf-transitio.htm EX-10.1 109627
3 EX-31.1 drnaex311.htm EX-31.1 9033
4 EX-31.2 drnaex312.htm EX-31.2 8952
5 EX-32.1 drnaex321.htm EX-32.1 8569
11 drna-20200331_g1.jpg GRAPHIC 186004
12 drna-20200331_g2.jpg GRAPHIC 480599
  Complete submission text file 0001399529-20-000041.txt   6776204

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT drna-20200331.xsd EX-101.SCH 40252
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT drna-20200331_cal.xml EX-101.CAL 56678
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT drna-20200331_def.xml EX-101.DEF 172757
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT drna-20200331_lab.xml EX-101.LAB 419429
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT drna-20200331_pre.xml EX-101.PRE 280505
19 EXTRACTED XBRL INSTANCE DOCUMENT drna-20200331_htm.xml XML 705436
Mailing Address 33 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 33 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36281 | Film No.: 20856960
SIC: 2834 Pharmaceutical Preparations